Dr. Beena Pillai Takes Helm as Director of Rajiv Gandhi Centre for Biotechnology
In a significant appointment for India's scientific community, Dr. Beena Pillai has assumed the role of new director at the Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram. This move marks a pivotal leadership transition at one of the nation's premier biotechnology research institutes.
Cabinet Approval and Appointment Details
The Appointments Committee of the Union Cabinet has officially approved Dr. Pillai's appointment for a five-year term. She succeeds Dr. Chandrabhas Narayana, who completed his tenure as director in September last year, bringing fresh expertise to guide RGCB's future research initiatives.
Background and Scientific Expertise
Dr. Beena Pillai is an accomplished scientist with a distinguished career in RNA biology and neuronal development. Her laboratory at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) in New Delhi has been at the forefront of studying:
- The critical role of RNAs in early development and neurogenesis
- Their impact on adult behavior and disease susceptibility
- miRNA markers for various human diseases
Born in Kalady, Kerala, Dr. Pillai's academic journey is impressive:
- She completed her B.Sc from Ramnarain Ruia College in Mumbai
- Earned an integrated MS-PhD from the Indian Institute of Science (IISc) in Bengaluru
- Joined CSIR-IGIB as a young scientist, where she has made substantial contributions
Recognition and Awards
Throughout her career, Dr. Pillai has received numerous prestigious awards, including:
- National Bioscience Award
- INSA Young Scientist Award
- CSIR Young Scientist Award in Biological Sciences
These accolades underscore her significant contributions to the field of biological sciences and her potential to lead RGCB effectively.
About Rajiv Gandhi Centre for Biotechnology
The Rajiv Gandhi Centre for Biotechnology (RGCB) operates as a national institute under the Biotechnology Research and Innovation Council (BRIC). It serves as a hub for cutting-edge research in biotechnology, focusing on innovation and scientific advancement that addresses both national and global challenges.
Dr. Pillai's appointment is expected to bring renewed vigor and direction to the institute's research programs, particularly in areas aligned with her expertise in RNA biology and neurodevelopment.
